WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Lyell Immunopharma revenue was $61.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $11.0k, down 67.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LYEL annual revenue was $61.0k, with -53.1% growth year-over-year.

LYEL past revenue growth

How has LYEL's revenue growth performed historically?

Company
-53.08%
Industry
511.06%
Market
20.87%
LYEL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LYEL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LYEL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LYEL revenue history

Current Revenue
$61.0k
Current Earnings
-$343.0M
Current Profit Margin
-562,285.2%

Be the first to know when LYEL announces revenue.

LYEL Revenue History By Year

LYEL Yearly RevenueLYEL RevenueLYEL ChangeLYEL Revenue Growth
2024-12-31$61.00k-$69.00k-53.08%
2023-12-31$130.00k-$84.55M-99.85%
2022-12-31$84.68M$74.03M+695.15%
2021-12-31$10.65M$2.89M+37.31%
2020-12-31$7.76M$7.10M+1,080.52%
2019-12-31$657.00kN/AN/A

1 of 1

Lyell Immunopharma Revenue FAQ

What was LYEL's revenue last quarter?

Lyell Immunopharma (NASDAQ: LYEL) reported Q4 2024 revenue of $11.00 thousand up 15.38% year over year. In the same quarter last year, Lyell Immunopharma's revenue was $13.00 thousand.

What was Lyell Immunopharma's revenue in 2024?

Lyell Immunopharma's annual revenue for the twelve months ending Dec 31, 2024 was $61.00 thousand, a 53.08% decrease year over year.

How much does Lyell Immunopharma make in a day?

Based on Lyell Immunopharma annual revenue for the past five years, LYEL makes an average of $56,591.78 per day.

What was Lyell Immunopharma's annual revenue growth in the past year?

As of Q2 2025, Lyell Immunopharma's revenue has grown -53.08% year over year. This is 564.14 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Lyell Immunopharma's revenue in the past year totaled $61.00 thousand.

How much does Lyell Immunopharma make in a year?

Lyell Immunopharma's revenue by year for the past five years is:
  • Lyell Immunopharma's revenue for the twelve months ending Dec 31, 2024 was $61.00 thousand, a 53.08% decrease year over year.
  • Lyell Immunopharma's annual revenue for Dec 31, 2023 was $130.00 thousand, a 99.85% decrease from 2022.
  • Lyell Immunopharma's annual revenue for 2022 was $84.68 million, a 695.15% increase from 2021.
  • Lyell Immunopharma's annual revenue for 2021 was $10.65 million, a 37.31% increase from 2020.
  • Lyell Immunopharma's annual revenue for 2020 was $7.76 million, a 1,080.52% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.